We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Bilibili
BILI
$7.84B
| $22.4K | ﹤0.01% |
1,485
+428
| +40% | +$7.86K |
|
|
SF
1027
Stifel
SF
$12.6B
| $22.4K | ﹤0.01% |
563
-16
| -3% | -$624 |
|
|
PDCO
1028
DELISTED
Patterson Companies, Inc.
PDCO
| $22.3K | ﹤0.01% |
670
-40
| -6% | -$1.1K |
|
1029
Watsco Inc
WSO
$13.6B
| $22.1K | ﹤0.01% |
58
+2
| +4% | +$678 |
|
|
MPT
1030
Medical Properties Trust
MPT
$2.81B
| $22.1K | ﹤0.01% |
2,388
+190
| +9% | +$1.61K |
|
1031
Revvity
RVTY
$12.8B
| $22.1K | ﹤0.01% |
186
-109
| -37% | -$13.4K |
|
1032
Tapestry
TPR
$32.8B
| $22K | ﹤0.01% |
515
+13
| +3% | +$541 |
|
|
CHX
1033
DELISTED
ChampionX
CHX
| $22K | ﹤0.01% |
710
+51
| +8% | +$1.4K |
|
1034
Service Corp International
SCI
$11.6B
| $22K | ﹤0.01% |
341
-2
| -0.6% | -$134 |
|
1035
State Street SPDR MSCI USA Gender Diversity ETF
SHE
$336M
| $22K | ﹤0.01% |
250
| – | – |
|
1036
Entergy
ETR
$50B
| $22K | ﹤0.01% |
452
+84
| +23% | +$4.35K |
|
|
SVC
1037
Service Properties Trust
SVC
$1.07B
| $22K | ﹤0.01% |
506
+51
| +11% | +$2.24K |
|
1038
Cameco
CCJ
$42.4B
| $22K | ﹤0.01% |
701
+8
| +1% | +$225 |
|
1039
Hancock Whitney
HWC
$6.24B
| $22K | ﹤0.01% |
572
| – | – |
|
1040
ScottsMiracle-Gro
SMG
$3.66B
| $21.9K | ﹤0.01% |
350
| – | – |
|
1041
HealthEquity
HQY
$8.75B
| $21.9K | ﹤0.01% |
347
+45
| +15% | +$2.61K |
|
1042
CNX Resources
CNX
$5.2B
| $21.9K | ﹤0.01% |
1,236
-260
| -17% | -$4.2K |
|
1043
KE Holdings
BEKE
$18.8B
| $21.9K | ﹤0.01% |
1,473
+296
| +25% | +$4.83K |
|
1044
SoFi Technologies
SOFI
$23.7B
| $21.8K | ﹤0.01% |
2,616
+323
| +14% | +$2.11K |
|
1045
Federal Signal
FSS
$7.83B
| $21.8K | ﹤0.01% |
340
+114
| +50% | +$6.3K |
|
1046
Methanex
MEOH
$4.12B
| $21.8K | ﹤0.01% |
526
| – | – |
|
1047
CNB Financial Corp
CCNE
$1.03B
| $21.7K | ﹤0.01% |
1,229
+1,177
| +2,263% | +$21.1K |
|
1048
Global X Internet of Things ETF
SNSR
$223M
| $21.7K | ﹤0.01% |
627
| – | – |
|
1049
IPG Photonics
IPGP
$3.84B
| $21.6K | ﹤0.01% |
159
| – | – |
|
1050
Everest Group
EG
$14.4B
| $21.5K | ﹤0.01% |
63
-2
| -3% | -$722 |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.